{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "increases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "be:NFkappaB",
      "entity_text" : "NF-kappaB",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:P01375",
      "entity_text" : "TNF",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "By detailed analysis of the time course of NF-kappaB activation, we found that UBE2L3 in conjunction with LUBAC had a more potent effect in dysregulating the late phase of TNF induced NF-kappaB activation, peaking at 9-10 hr, and that this effect could be suppressed by variant p.Cys885Ser HOIP, confirming that the effect of UBE2L3 on NF-kappaB is mediated through its interaction with HOIP.",
  "reading_complete" : "2020-08-08T12:01:17Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T11:59:36Z",
  "trigger" : "induced",
  "evidence" : [ "TNF-induced NF-kappaB" ],
  "pmc_id" : "4320258",
  "score" : 0
}